Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

NCT00684463 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Nausea
Vomiting

Interventions

DRUG: Palonosetron

Sponsor

Merck Sharp & Dohme LLC